Lv1
50 积分 2025-03-24 加入
Double Peaking Phenomena in Pharmacokinetic Disposition Revisited
3个月前
已完结
A Randomized Study on the Bioequivalence of Desloratadine in Healthy Chinese Subjects and the Association of Different Metabolic Phenotypes With UGT2B10 and CYP2C8 Genotypes
3个月前
已完结
CYP1A2*F Polymorphism Contributes at Least Partially to the Variability of Plasma Levels of Dehydroaripiprazole, an Active Metabolite of Aripiprazole, in Schizophrenic Patients
4个月前
已完结
Influence of CYP2D6 Gene Polymorphisms on the Pharmacokinetics of Aripiprazole in Healthy Chinese Subjects
4个月前
已完结
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics
5个月前
已完结
Visual Detection of ACE I/D Polymorphism Using T-ARMS-PCR Combined with a Lateral Flow Assay and Its Clinical Application
5个月前
已完结
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions
5个月前
已完结
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions
5个月前
已关闭
Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects
5个月前
已完结
Co-administration of a nanosuspension of a poorly soluble basic compound and a solution of a proton pump inhibitor—the importance of gastrointestinal pH and solubility for the in vivo exposure
6个月前
已完结